Company profile: Dottikon ES
1.1 - Company Overview
Company description
- Provider of chemicals, intermediates, and active pharmaceutical ingredients for chemical, biotech, and pharmaceutical industries; cGMP API manufacturing; process development (R&D, routefinding, process design); small-, pilot-, and large-scale production with expertise in hazardous reactions and high-potency products; project and quality management; recycling and waste treatment including thermal recovery and waste water treatment and purification.
Products and services
- Large-Scale Production: Runs industrial-grade multipurpose plants for large-volume manufacturing, safely handling hazardous reactions and specialized processes for chemicals and intermediates
- Active Pharmaceutical Ingredients (APIs): Engineers cGMP-compliant small-volume APIs for clinical trials and marketed products, following stringent cGMP guidelines for pharmaceutical manufacturing
- Pilot Production: Operates cGMP pilot plants to scale up high-potency products, supporting technology transfer and process development with controlled pilot-scale operations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Dottikon ES
Boca Biolistics
HQ: United States
Website
- Description: Provider of hybrid CRO and biobank services, delivering human biospecimens across oncology and other diseases; end-to-end contract research to support development and market approval of diagnostic technologies; CLIA-certified, CAP-accredited reference lab testing; COVID-19 serology and PCR; and oncology research solutions combining clinical research, data analytics, and industry leading clinical and molecular datasets to enable precision medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Boca Biolistics company profile →
Science Group
HQ: United Kingdom
Website
- Description: Provider of independent advisory and advanced product development services for science and technology initiatives. Through specialist companies Sagentia, Oakland Innovation, OTM Consulting and Leatherhead Food Research, the group collaborates with clients in key vertical markets to deliver clear returns on technology and R&D.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Science Group company profile →
Analgesic Solutions
HQ: United States
Website
- Description: Provider of consulting, innovative tools, data science, technology, and training to reduce risks in clinical trials; privately held.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Analgesic Solutions company profile →
Magle Chemoswed
HQ: Sweden
Website
- Description: Provider of integrated pharmaceutical development and GMP-compliant manufacturing from pre-clinical to commercial scale, including inhalation services (dry powder formulation, micronization, crystallinity restoration), solid-state analysis and characterization (polymorph and salt screening), analytical method development and validation, organic chemistry process development, crystallization support, and batch release testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Magle Chemoswed company profile →
Catalyst Clinical Research
HQ: United States
Website
- Description: Provider of clinical operation solutions to biotechnology, pharmaceutical, and medical device companies, built on over two decades of experience supporting clinical development with therapeutically aligned experts and customized solutions. Offers Catalyst Oncology, a full-service CRO for cancer drug development, and Catalyst Flex, FSP services in clinical operations, data management, biostatistics, programming, safety, and medical writing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Catalyst Clinical Research company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Dottikon ES
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Dottikon ES
2.2 - Growth funds investing in similar companies to Dottikon ES
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Dottikon ES
4.2 - Public trading comparable groups for Dottikon ES
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →